Clinical Trials in Salt Lake City

Showing 11861-11880 of 14,325 trials

Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients

NCT01954004

This registry is intended to evaluate the impact of genomic test results towards selecting a first-line therapy option for newly diagnosed localized prostate cancer patients.

Prostate Cancer

Myriad Genetic Laboratories, Inc.1,270 participantsStarted Apr 2013

Salt Lake City, Utah, United States

WITHDRAWNPhase 2/3< 1 mile

Etanercept for the Treatment of Chronic Urticaria

NCT01030120

The purpose of this study is to evaluate the safety and efficacy of etanercept for patients with chronic idiopathic urticaria unresponsive to antihistamines.

Chronic Idiopathic Urticaria

University of UtahStarted Dec 2010

Salt Lake City, Utah, United States

COMPLETEDPhase 3< 1 mile

Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva

NCT00003325

RATIONALE: Lymphatic mapping may improve the ability to detect cancer of the vulva. PURPOSE: This phase III trial is studying how well lymphatic mapping works in treating patients with stage I or stage II cancer of the vulva.

Vulvar Cancer

Gynecologic Oncology Group515 participantsStarted Dec 1999

Little Rock, Arkansas, United States • Long Beach, California, United States • San Francisco, California, United States +69 more locations

Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients

Etanercept for the Treatment of Chronic Urticaria

Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva

Find Trials by Condition in Salt Lake City

A Twelve Week Safety and Efficacy Study in Rosacea

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

A New Prenatal Blood Test for Down Syndrome

Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg

Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)

Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension

A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis

A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer

New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients

Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer

Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C

Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin

Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis

In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products

Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression